amycretin vs tirzepatide What is the pipeline for future medications for obesity? Amycretin, a novel, unimolecular GLP-1

It affects men more than women

Retatrutide An investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, demonstrating body-weight change of up to 24.2% in phase 2 trials alongside improvements in cardiometabolic parameters and hepatic steatosis

#Gliprons #GLP1 #SmallMolecule #DrugDiscovery #Orforglipron #MedicinalChemistry #Semaglutide Update : You may connect us for Orforglipron Intermediates Recent Update : HRS-7535 (also known as KAI-7535 or Safiglipron) is an oral, small-molecule GLP-1 receptor agonist originally developed by Jiangsu Hengrui Pharmaceuticals Co., Ltd

He uses an example where the desired outcome is weight gain to explain

Neurotrauma 26, 10951110